Free Trial
NYSE:JNJ

Johnson & Johnson Q3 2025 Earnings Report

Johnson & Johnson logo
$188.50 -0.14 (-0.07%)
As of 11:55 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Johnson & Johnson EPS Results

Actual EPS
N/A
Consensus EPS
$2.78
Beat/Miss
N/A
One Year Ago EPS
N/A

Johnson & Johnson Revenue Results

Actual Revenue
N/A
Expected Revenue
$23.73 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Johnson & Johnson Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Tuesday, October 14, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Johnson & Johnson Earnings Headlines

Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
Johnson & Johnson (NYSE:JNJ) Price Target Raised to $198.00
Johnson & Johnson (NYSE:JNJ) Stock Rating Upgraded by Wells Fargo & Company
See More Johnson & Johnson Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Johnson & Johnson? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Johnson & Johnson and other key companies, straight to your email.

About Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) (NYSE: JNJ) is a diversified global healthcare company that develops, manufactures and sells a broad range of products in three primary business segments: Pharmaceuticals, Medical Devices and Consumer Health. Founded in 1886 by brothers Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson, the company pioneered sterile surgical dressings and has since expanded into prescription medicines, diagnostics and advanced medical technologies, as well as over-the-counter healthcare products.

In its Pharmaceuticals segment, Johnson & Johnson researches and commercializes treatments in areas such as immunology, oncology, neuroscience and infectious diseases. The Medical Devices segment offers a wide array of surgical systems, orthopaedic devices, cardiovascular care solutions and vision care products. Within Consumer Health, the company markets well-known brands in skin care, baby care, wound care, oral hygiene and women’s health. Together, these divisions serve healthcare professionals, consumers and patients around the world.

Headquartered in New Brunswick, New Jersey, Johnson & Johnson operates in more than 60 countries and sells products in virtually every market worldwide. The company maintains research and development facilities across North America, Europe and Asia, supporting collaborations with academic institutions and biotechnology firms. As of 2022, Johnson & Johnson is led by Chairman and Chief Executive Officer Joaquin Duato, under whose leadership the company continues to pursue innovation and sustainable growth within the global healthcare industry.

View Johnson & Johnson Profile

More Earnings Resources from MarketBeat